Page 14 - Recommendation Statement News Today

Adds Deuruxolitinib, a Potential Best-in-Class Oral JAK Inhibitor for the Treatment of Alopecia Areata, an Autoimmune Dermatological Disease Leverages Sun Pharma's Global Infrastructure

/PRNewswire/ -- In its ongoing work to address health disparities for Black men related to prostate cancer, the Prostate Cancer Foundation (PCF) today...

/PRNewswire/ -- In its ongoing work to address health disparities for Black men related to prostate cancer, the Prostate Cancer Foundation (PCF) today...

Transaction focused on Bylvay (odevixibat), the first-approved treatment in progressive familial intrahepatic cholestasis in U.S. and E.U., with potential in other rare diseases Acquisition

Full Text View - ClinicalTrials.gov Hopkins P J Pediatr. 2017;187:253-257. doi: 10.1016/j.jpeds.2017.05.006. Epub 2017 Jun 1. ... | January 9, 2023

/PRNewswire/ -- GTCR, a leading private equity firm, announced today that portfolio company Paya Holdings Inc. (NASDAQ: PAYA), a leading integrated payments...

Ipsen and Albireo announced that they have entered into a definitive merger agreement under which Ipsen will acquire Albireo, a leading innovator in bile-acid modulators to treat pediatric and adult cholestatic liver diseases.

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing novel treatments for resistant and uncontrolled hypertension as well as chronic kidney disease. The acquisition will bolster AstraZeneca’s ...

/PRNewswire/ - Enghouse Systems Limited (TSX: ENGH) ("Enghouse") today announced that its indirect wholly-owned subsidiary, Cosmos Merger Sub, Inc., has...

MARKHAM, ON, Jan. 6, 2023 /PRNewswire/ -- Enghouse Systems Limited (TSX: ENGH) ("Enghouse") today announced that its indirect wholly-owned subsidiary, Cosmos Merger Sub, Inc., has commenced